We are live on ! Find out more
KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

103 hedge funds and large institutions have $707M invested in Chinook Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

257% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 7

194% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 17

96% more capital invested

Capital invested by funds: $362M → $707M (+$345M)

21% more funds holding

Funds holding: 85 → 103 (+18)

2% more call options, than puts

Call options by funds: $47K | Put options by funds: $46K

Holders
103
Holders Change
+18
Holders Change %
+21.18%
% of All Funds
1.59%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
25
Increased
50
Reduced
17
Closed
7
Calls
$47K
Puts
$46K
Net Calls
+$1K
Net Calls Change
-$153K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$25.6M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$19.3M
3
VA
VR Adviser
New York
+$18.3M
4
SB
Samsara BioCapital
California
+$17.3M
5
RCM
RA Capital Management
Massachusetts
+$14.2M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.47M
2
AC
Armistice Capital
New York
-$2.68M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.32M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.99M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
OCA
26
Octagon Capital Advisors
New York
$8.15M +$7.12M +500,000 New
GPP
27
Great Point Partners
Connecticut
$6.36M +$5.55M +390,041 New
Renaissance Technologies
28
Renaissance Technologies
New York
$6.01M -$2.32M -162,920 -31%
Millennium Management
29
Millennium Management
New York
$5.72M -$4.47M -314,032 -47%
Northern Trust
30
Northern Trust
Illinois
$5.68M +$631K +44,339 +15%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$5.17M -$894K -62,800 -17%
EAM
32
Erste Asset Management
Austria
$4.94M +$641K +45,000 +17%
SCM
33
Soleus Capital Management
Connecticut
$4.87M +$4.25M +298,700 New
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$4.76M +$1.22M +86,052 +42%
IBT
35
International Biotechnology Trust
United Kingdom
$4.71M +$774K +54,389 +23%
Goldman Sachs
36
Goldman Sachs
New York
$3.56M +$332K +23,289 +12%
Bank of America
37
Bank of America
North Carolina
$3.55M +$19.5K +1,373 +0.6%
Two Sigma Investments
38
Two Sigma Investments
New York
$3.45M -$1.61M -112,853 -35%
Marshall Wace
39
Marshall Wace
United Kingdom
$3.05M +$2.66M +187,027 New
Ensign Peak Advisors
40
Ensign Peak Advisors
Utah
$3.04M +$1.18M +83,029 +81%
PAMP
41
Polar Asset Management Partners
Ontario, Canada
$2.97M +$2.59M +182,300 New
AG
42
Artal Group
Luxembourg
$2.94M – – –
Walleye Capital
43
Walleye Capital
New York
$2.88M +$2.51M +176,551 New
N
44
Nuveen
North Carolina
$2.52M -$339K -23,819 -13%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$2.31M +$170K +11,952 +9%
JP Morgan Chase
46
JP Morgan Chase
New York
$2.12M -$15.9K -1,114 -0.8%
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$2.09M +$1.37M +95,966 +299%
SFM
48
Sphera Funds Management
Israel
$1.82M +$1.59M +111,653 New
Charles Schwab
49
Charles Schwab
California
$1.67M +$249K +17,501 +21%
MIM
50
Monashee Investment Management
Massachusetts
$1.55M +$1.35M +95,000 New
1
2
3 4 5

KDNY Hedge Fund Activity: Q4 2021 in Review

103 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q4 2021, worth a combined $707M — up 96% from $362M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new KDNY positions and 7 closed out — a net gain of 18 holders — while 50 added to existing stakes and 17 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $25.6M. The largest seller was Millennium Management, cutting an estimated $4.47M.

  • 103 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q4 2021, up from 85 in Q3 2021.
  • Funds reported $707M of Chinook Therapeutics, Inc. Common Stock stock for Q4 2021, up 96% quarter-over-quarter.
  • 25 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q4 2021 and 7 closed out, a net change of +18 holders.
  • The largest Chinook Therapeutics, Inc. Common Stock buyer in Q4 2021 was BVF Inc, an estimated $25.6M added.
  • The largest Chinook Therapeutics, Inc. Common Stock seller in Q4 2021 was Millennium Management, an estimated $4.47M sold.

Based on aggregated 13F filings for Q4 2021.